Adtalem Global Education Inc. (CVSA) – What Are Brokerages Thinking About This Stock?

Shares of Adtalem Global Education Inc. (NYSE:CVSA) have earned a consensus rating of “Hold” from the five brokerages that are currently covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $151.67.

Several equities research analysts recently weighed in on CVSA shares. Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Sunday, September 27th. BMO Capital Markets reduced their price objective on Adtalem Global Education from $148.00 to $145.00 and set an “outperform” rating for the company in a research report on Monday, October 5th. Truist Financial lowered Adtalem Global Education from a “buy” rating to a “hold” rating and set a $140.00 price objective on the stock. in a report on Thursday, September 3rd. Finally, Weiss Ratings upgraded Adtalem Global Education from a “hold (c)” rating to a “hold (c+)” rating in a research report on Wednesday, October 21st.

Insider Transactions at Adtalem Global Education

In other Adtalem Global Education news, CEO Stephen Beard sold 4,667 shares of Adtalem Global Education stock in a transaction on Friday, October 9th. The shares were sold at an average price of $130.77, for a total transaction of $610,303.59. Following the sale, the chief executive officer owned 469,158 shares in the company, valued at $61,351,791.66. The trade was a 0.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert Phelan sold 2,186 shares of the business’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $135.15, for a total transaction of $295,437.90. Following the completion of the sale, the chief financial officer directly owned 48,306 shares in the company, valued at $6,528,555.90. This trade represents a 4.33% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 20,365 shares of company stock valued at $2,704,088 in the last ninety days. 2.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Adtalem Global Education

A hedge fund recently raised its position in Adtalem Global Education stock. Kendall Capital Management increased its stake in shares of Adtalem Global Education Inc. (NYSE:CVSA) by 23.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,375 shares of the company’s stock after buying an additional 2,753 shares during the period. Kendall Capital Management’s holdings in Adtalem Global Education were worth $1,757,000 at the end of the most recent quarter. Institutional investors and hedge funds own 98.84% of the company’s stock.

Adtalem Global Education Stock Down 0.8%

Shares of CVSA stock opened at $123.03 on Friday. Adtalem Global Education has a 12 month low of $86.97 and a 12 month high of $142.13. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 0.35. The firm has a market cap of $4.09 billion, a PE ratio of 14.27, a price-to-earnings-growth ratio of 0.91 and a beta of 0.70. The stock has a 50 day moving average of $127.61 and a 200-day moving average of $122.09.

Adtalem Global Education (NYSE:CVSA) last announced its quarterly earnings data on Thursday, October 29th. The company reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.29. Adtalem Global Education had a net margin of 12.84% and a return on equity of 21.79%. The business had revenue of $511.53 million for the quarter. On average, equities analysts predict that Adtalem Global Education will post 9.10 EPS for the current year.

Adtalem Global Education Company Profile

Adtalem Global Education, Inc is an education services company that provides healthcare and professional education through institutions serving students in the United States and internationally. The company focuses on preparing students for careers in healthcare, including nursing, medicine, veterinary medicine and other health-related fields.

Its portfolio has included Chamberlain University, Walden University, the American University of the Caribbean School of Medicine, Ross University School of Medicine and Ross University School of Veterinary Medicine.